Global Hemangioma Market Growth (Status and Outlook) 2022-2028
- LP 4759463
- 89 Pages
- January 2022
- Pharmaceuticals
The United States Hemangioma market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hemangioma market, reaching US$ million by the year 2028. As for the Europe Hemangioma landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hemangioma players cover Akrimax, AstraZeneca, Novartis, and Cutting Edge Laser Technologies, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemangioma market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Medical Therapy
Laser Therapy
Surgery
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Adult
Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Akrimax
AstraZeneca
Novartis
Cutting Edge Laser Technologies
Pfizer
Pierre Fabre
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemangioma Market Size 2017-2028
2.1.2 Hemangioma Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Hemangioma Segment by Type
2.2.1 Medical Therapy
2.2.2 Laser Therapy
2.2.3 Surgery
2.2.4 Other
2.3 Hemangioma Market Size by Type
2.3.1 Hemangioma Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Hemangioma Market Size Market Share by Type (2017-2022)
2.4 Hemangioma Segment by Application
2.4.1 Adult
2.4.2 Child
2.5 Hemangioma Market Size by Application
2.5.1 Hemangioma Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Hemangioma Market Size Market Share by Application (2017-2022)
3 Hemangioma Market Size by Player
3.1 Hemangioma Market Size Market Share by Players
3.1.1 Global Hemangioma Revenue by Players (2020-2022)
3.1.2 Global Hemangioma Revenue Market Share by Players (2020-2022)
3.2 Global Hemangioma Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Hemangioma by Regions
4.1 Hemangioma Market Size by Regions (2017-2022)
4.2 Americas Hemangioma Market Size Growth (2017-2022)
4.3 APAC Hemangioma Market Size Growth (2017-2022)
4.4 Europe Hemangioma Market Size Growth (2017-2022)
4.5 Middle East & Africa Hemangioma Market Size Growth (2017-2022)
5 Americas
5.1 Americas Hemangioma Market Size by Country (2017-2022)
5.2 Americas Hemangioma Market Size by Type (2017-2022)
5.3 Americas Hemangioma Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemangioma Market Size by Region (2017-2022)
6.2 APAC Hemangioma Market Size by Type (2017-2022)
6.3 APAC Hemangioma Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hemangioma by Country (2017-2022)
7.2 Europe Hemangioma Market Size by Type (2017-2022)
7.3 Europe Hemangioma Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hemangioma by Region (2017-2022)
8.2 Middle East & Africa Hemangioma Market Size by Type (2017-2022)
8.3 Middle East & Africa Hemangioma Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Hemangioma Market Forecast
10.1 Global Hemangioma Forecast by Regions (2023-2028)
10.1.1 Global Hemangioma Forecast by Regions (2023-2028)
10.1.2 Americas Hemangioma Forecast
10.1.3 APAC Hemangioma Forecast
10.1.4 Europe Hemangioma Forecast
10.1.5 Middle East & Africa Hemangioma Forecast
10.2 Americas Hemangioma Forecast by Country (2023-2028)
10.2.1 United States Hemangioma Market Forecast
10.2.2 Canada Hemangioma Market Forecast
10.2.3 Mexico Hemangioma Market Forecast
10.2.4 Brazil Hemangioma Market Forecast
10.3 APAC Hemangioma Forecast by Region (2023-2028)
10.3.1 China Hemangioma Market Forecast
10.3.2 Japan Hemangioma Market Forecast
10.3.3 Korea Hemangioma Market Forecast
10.3.4 Southeast Asia Hemangioma Market Forecast
10.3.5 India Hemangioma Market Forecast
10.3.6 Australia Hemangioma Market Forecast
10.4 Europe Hemangioma Forecast by Country (2023-2028)
10.4.1 Germany Hemangioma Market Forecast
10.4.2 France Hemangioma Market Forecast
10.4.3 UK Hemangioma Market Forecast
10.4.4 Italy Hemangioma Market Forecast
10.4.5 Russia Hemangioma Market Forecast
10.5 Middle East & Africa Hemangioma Forecast by Region (2023-2028)
10.5.1 Egypt Hemangioma Market Forecast
10.5.2 South Africa Hemangioma Market Forecast
10.5.3 Israel Hemangioma Market Forecast
10.5.4 Turkey Hemangioma Market Forecast
10.5.5 GCC Countries Hemangioma Market Forecast
10.6 Global Hemangioma Forecast by Type (2023-2028)
10.7 Global Hemangioma Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Akrimax
11.1.1 Akrimax Company Information
11.1.2 Akrimax Hemangioma Product Offered
11.1.3 Akrimax Hemangioma Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Akrimax Main Business Overview
11.1.5 Akrimax Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Hemangioma Product Offered
11.2.3 AstraZeneca Hemangioma Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Hemangioma Product Offered
11.3.3 Novartis Hemangioma Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Cutting Edge Laser Technologies
11.4.1 Cutting Edge Laser Technologies Company Information
11.4.2 Cutting Edge Laser Technologies Hemangioma Product Offered
11.4.3 Cutting Edge Laser Technologies Hemangioma Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Cutting Edge Laser Technologies Main Business Overview
11.4.5 Cutting Edge Laser Technologies Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Hemangioma Product Offered
11.5.3 Pfizer Hemangioma Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Pierre Fabre
11.6.1 Pierre Fabre Company Information
11.6.2 Pierre Fabre Hemangioma Product Offered
11.6.3 Pierre Fabre Hemangioma Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Pierre Fabre Main Business Overview
11.6.5 Pierre Fabre Latest Developments
12 Research Findings and Conclusion
Table 1. Hemangioma Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Medical Therapy
Table 3. Major Players of Laser Therapy
Table 4. Major Players of Surgery
Table 5. Major Players of Other
Table 6. Hemangioma Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Hemangioma Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Hemangioma Market Size Market Share by Type (2017-2022)
Table 9. Hemangioma Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Hemangioma Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Hemangioma Market Size Market Share by Application (2017-2022)
Table 12. Global Hemangioma Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Hemangioma Revenue Market Share by Player (2020-2022)
Table 14. Hemangioma Key Players Head office and Products Offered
Table 15. Hemangioma Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Hemangioma Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Hemangioma Market Size Market Share by Regions (2017-2022)
Table 20. Americas Hemangioma Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Hemangioma Market Size Market Share by Country (2017-2022)
Table 22. Americas Hemangioma Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Hemangioma Market Size Market Share by Type (2017-2022)
Table 24. Americas Hemangioma Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Hemangioma Market Size Market Share by Application (2017-2022)
Table 26. APAC Hemangioma Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Hemangioma Market Size Market Share by Region (2017-2022)
Table 28. APAC Hemangioma Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Hemangioma Market Size Market Share by Type (2017-2022)
Table 30. APAC Hemangioma Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Hemangioma Market Size Market Share by Application (2017-2022)
Table 32. Europe Hemangioma Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Hemangioma Market Size Market Share by Country (2017-2022)
Table 34. Europe Hemangioma Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Hemangioma Market Size Market Share by Type (2017-2022)
Table 36. Europe Hemangioma Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Hemangioma Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Hemangioma Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Hemangioma Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Hemangioma Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Hemangioma Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Hemangioma Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Hemangioma Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Hemangioma
Table 45. Key Market Challenges & Risks of Hemangioma
Table 46. Key Industry Trends of Hemangioma
Table 47. Global Hemangioma Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Hemangioma Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Hemangioma Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Hemangioma Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Hemangioma Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Hemangioma Market Size Market Share Forecast by Application (2023-2028)
Table 53. Akrimax Details, Company Type, Hemangioma Area Served and Its Competitors
Table 54. Akrimax Hemangioma Product Offered
Table 55. Akrimax Hemangioma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Akrimax Main Business
Table 57. Akrimax Latest Developments
Table 58. AstraZeneca Details, Company Type, Hemangioma Area Served and Its Competitors
Table 59. AstraZeneca Hemangioma Product Offered
Table 60. AstraZeneca Main Business
Table 61. AstraZeneca Hemangioma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. AstraZeneca Latest Developments
Table 63. Novartis Details, Company Type, Hemangioma Area Served and Its Competitors
Table 64. Novartis Hemangioma Product Offered
Table 65. Novartis Main Business
Table 66. Novartis Hemangioma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Novartis Latest Developments
Table 68. Cutting Edge Laser Technologies Details, Company Type, Hemangioma Area Served and Its Competitors
Table 69. Cutting Edge Laser Technologies Hemangioma Product Offered
Table 70. Cutting Edge Laser Technologies Main Business
Table 71. Cutting Edge Laser Technologies Hemangioma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Cutting Edge Laser Technologies Latest Developments
Table 73. Pfizer Details, Company Type, Hemangioma Area Served and Its Competitors
Table 74. Pfizer Hemangioma Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer Hemangioma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Pfizer Latest Developments
Table 78. Pierre Fabre Details, Company Type, Hemangioma Area Served and Its Competitors
Table 79. Pierre Fabre Hemangioma Product Offered
Table 80. Pierre Fabre Main Business
Table 81. Pierre Fabre Hemangioma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Pierre Fabre Latest Developments
List of Figures
Figure 1. Hemangioma Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hemangioma Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Hemangioma Market Size Market Share by Type in 2021
Figure 7. Hemangioma in Adult
Figure 8. Global Hemangioma Market: Adult (2017-2022) & ($ Millions)
Figure 9. Hemangioma in Child
Figure 10. Global Hemangioma Market: Child (2017-2022) & ($ Millions)
Figure 11. Global Hemangioma Market Size Market Share by Application in 2021
Figure 12. Global Hemangioma Revenue Market Share by Player in 2021
Figure 13. Global Hemangioma Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Hemangioma Market Size 2017-2022 ($ Millions)
Figure 15. APAC Hemangioma Market Size 2017-2022 ($ Millions)
Figure 16. Europe Hemangioma Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Hemangioma Market Size 2017-2022 ($ Millions)
Figure 18. Americas Hemangioma Value Market Share by Country in 2021
Figure 19. Americas Hemangioma Consumption Market Share by Type in 2021
Figure 20. Americas Hemangioma Market Size Market Share by Application in 2021
Figure 21. United States Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Hemangioma Market Size Market Share by Region in 2021
Figure 26. APAC Hemangioma Market Size Market Share by Application in 2021
Figure 27. China Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Hemangioma Market Size Market Share by Country in 2021
Figure 34. Europe Hemangioma Market Size Market Share by Type in 2021
Figure 35. Europe Hemangioma Market Size Market Share by Application in 2021
Figure 36. Germany Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Hemangioma Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Hemangioma Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Hemangioma Market Size Market Share by Application in 2021
Figure 44. Egypt Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Hemangioma Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Hemangioma Market Size 2023-2028 ($ Millions)
Figure 50. APAC Hemangioma Market Size 2023-2028 ($ Millions)
Figure 51. Europe Hemangioma Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Hemangioma Market Size 2023-2028 ($ Millions)
Figure 53. United States Hemangioma Market Size 2023-2028 ($ Millions)
Figure 54. Canada Hemangioma Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Hemangioma Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Hemangioma Market Size 2023-2028 ($ Millions)
Figure 57. China Hemangioma Market Size 2023-2028 ($ Millions)
Figure 58. Japan Hemangioma Market Size 2023-2028 ($ Millions)
Figure 59. Korea Hemangioma Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Hemangioma Market Size 2023-2028 ($ Millions)
Figure 61. India Hemangioma Market Size 2023-2028 ($ Millions)
Figure 62. Australia Hemangioma Market Size 2023-2028 ($ Millions)
Figure 63. Germany Hemangioma Market Size 2023-2028 ($ Millions)
Figure 64. France Hemangioma Market Size 2023-2028 ($ Millions)
Figure 65. UK Hemangioma Market Size 2023-2028 ($ Millions)
Figure 66. Italy Hemangioma Market Size 2023-2028 ($ Millions)
Figure 67. Russia Hemangioma Market Size 2023-2028 ($ Millions)
Figure 68. Spain Hemangioma Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Hemangioma Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Hemangioma Market Size 2023-2028 ($ Millions)
Figure 71. Israel Hemangioma Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Hemangioma Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Hemangioma Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
